Casey Janssen to undergo an MRI on his right shoulder

8 Comments

Nationals reliever Casey Janssen will undergo an MRI on his right shoulder, James Wagner of the Washington Post reports. According to Wagner, Janssen reported some abnormal soreness and had trouble getting loose in his last outing on Monday against the Yankees.

Janssen is no stranger to shoulder injuries, as they have nagged him for most of his career. Per Baseball Prospectus, he has had surgery on his shoulder twice: in March 2008 for his labrum, and in November 2012 for A/C joint spurs. He also spent a month and a half on the disabled list last year due to lower back issues. Over 45 2/3 innings with the Blue Jays last season, he finished with a 3.94 ERA and a 28/7 K/BB ratio.

Wagner notes that if Janssen needs to go on the disabled list, the Nationals could turn to Blake Treinen. Treinen made seven starts and eight relief appearances for the Nationals last season, compiling a 2.49 ERA and a 30/13 K/BB ratio in 50 2/3 innings.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.